← Browse by Condition
Medical Condition
fl lymphoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT07249905 Phase 1, Phase 2
Recruiting
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Enrollment
180 pts
Location
Australia
Sponsor
ModeX Therapeutics, An OPKO He...
NCT04390737 Phase 1, Phase 2
Recruiting
Evaluate the Safety and Clinical Activity of HH2853
Enrollment
254 pts
Location
United States, China
Sponsor
Haihe Biopharma Co., Ltd.